title: Letter regarding levosimendan in a rat model of severe verapamil poisoning.
authors.forename: Andis
authors.initials: A
authors.lastname: Graudins
mesh_terms: D000818:Animals; D000931:Antidotes / Q000008:administration & dosage / Q000494:pharmacology*; D002316:Cardiotonic Agents / Q000494:pharmacology; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000494:pharmacology*; D004195:Disease Models, Animal; D062787:Drug Overdose / Q000188:drug therapy / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects*; D006835:Hydrazones / Q000008:administration & dosage / Q000494:pharmacology*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D011724:Pyridazines / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D012720:Severity of Illness Index; D000077464:Simendan; D014665:Vasodilator Agents / Q000494:pharmacology; D014700:Verapamil
chemical_list: D000931:Antidotes; D002316:Cardiotonic Agents; D002317:Cardiovascular Agents; D006835:Hydrazones; D010726:Phosphodiesterase Inhibitors; D011724:Pyridazines; D014665:Vasodilator Agents; D000077464:Simendan; D014700:Verapamil